239 related articles for article (PubMed ID: 26747402)
1. Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic.
Fornai M; Antonioli L; Pellegrini C; Colucci R; Sacco D; Tirotta E; Natale G; Bartalucci A; Flaibani M; Renzulli C; Ghelardi E; Blandizzi C; Scarpignato C
Pharmacol Res; 2016 Feb; 104():186-96. PubMed ID: 26747402
[TBL] [Abstract][Full Text] [Related]
2. Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy.
Fornai M; Colucci R; Pellegrini C; Benvenuti L; Natale G; Ryskalin L; Blandizzi C; Antonioli L
Pharmacol Rep; 2020 Oct; 72(5):1347-1357. PubMed ID: 32583327
[TBL] [Abstract][Full Text] [Related]
3. Suppression of contractile activity in the small intestine by indomethacin and omeprazole.
Lichtenberger LM; Bhattarai D; Phan TM; Dial EJ; Uray K
Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G785-93. PubMed ID: 25721304
[TBL] [Abstract][Full Text] [Related]
4. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
[TBL] [Abstract][Full Text] [Related]
5. Role of antioxidative activity in the docosahexaenoic acid's enteroprotective effect in the indomethacin-induced small intestinal injury model.
Sánchez-Trigueros MI; Martínez-Vieyra IA; Pineda-Peña EA; Castañeda-Hernández G; Perez-Cruz C; Cerecedo D; Chávez-Piña AE
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4275-4285. PubMed ID: 38085291
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.
Xu D; Gao J; Gillilland M; Wu X; Song I; Kao JY; Owyang C
Gastroenterology; 2014 Feb; 146(2):484-96.e4. PubMed ID: 24161699
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy.
Fornai M; Pellegrini C; Benvenuti L; Tirotta E; Gentile D; Natale G; Ryskalin L; Colucci R; Piccoli E; Ghelardi E; Blandizzi C; Antonioli L
Nutrition; 2020 Feb; 70():110583. PubMed ID: 31739175
[TBL] [Abstract][Full Text] [Related]
9. Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine.
Bertrand V; Guimbaud R; Tulliez M; Mauprivez C; Sogni P; Couturier D; Giroud JP; Chaussade S; Chauvelot-Moachon L
Br J Pharmacol; 1998 Aug; 124(7):1385-94. PubMed ID: 9723949
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin-induced small intestinal injury is ameliorated by cilostazol, a specific PDE-3 inhibitor.
Higashiyama M; Hokari R; Kurihara C; Ueda T; Watanabe C; Tomita K; Komoto S; Okada Y; Kawaguchi A; Nagao S; Miura S
Scand J Gastroenterol; 2012 Sep; 47(8-9):993-1002. PubMed ID: 22934593
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of NSAID-Associated Intestinal Lesions in the Rat: Luminal Bacteria and Mucosal Inflammation as Targets for Prevention.
Colucci R; Pellegrini C; Fornai M; Tirotta E; Antonioli L; Renzulli C; Ghelardi E; Piccoli E; Gentile D; Benvenuti L; Natale G; Fulceri F; Palazón-Riquelme P; López-Castejón G; Blandizzi C; Scarpignato C
Front Pharmacol; 2018; 9():1340. PubMed ID: 30555323
[TBL] [Abstract][Full Text] [Related]
13. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.
Scarpignato C; Pelosini I
Chemotherapy; 2005; 51 Suppl 1():36-66. PubMed ID: 15855748
[TBL] [Abstract][Full Text] [Related]
14. Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice.
Justino PF; Melo LF; Nogueira AF; Costa JV; Silva LM; Santos CM; Mendes WO; Costa MR; Franco AX; Lima AA; Ribeiro RA; Souza MH; Soares PM
Br J Nutr; 2014 May; 111(9):1611-21. PubMed ID: 24503021
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans.
Scarpignato C; Dolak W; Lanas A; Matzneller P; Renzulli C; Grimaldi M; Zeitlinger M; Bjarnason I
Gastroenterology; 2017 Apr; 152(5):980-982.e3. PubMed ID: 28007576
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice.
Fukumoto K; Naito Y; Takagi T; Yamada S; Horie R; Inoue K; Harusato A; Hirata I; Omatsu T; Mizushima K; Hirai Y; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Kokura S; Ichikawa H; Kita M; Yoshikawa T
Int J Mol Med; 2011 Mar; 27(3):353-9. PubMed ID: 21249312
[TBL] [Abstract][Full Text] [Related]
18. Excessive Interleukin 18 Relate the Aggravation of Indomethacin-Induced Intestinal Ulcerogenic Lesions in Adjuvant-Induced Arthritis Rat.
Nagai N; Tanino T; Ito Y
Biol Pharm Bull; 2015; 38(10):1580-90. PubMed ID: 26424019
[TBL] [Abstract][Full Text] [Related]
19. Increased gap density predicts weakness of the epithelial barrier in vivo by confocal laser endomicroscopy in indomethacin-induced enteropathy.
Shi S; Wang H; Gao H; Li Z; Chen FX; Zuo XL; Li YQ
Dig Dis Sci; 2014 Jul; 59(7):1398-405. PubMed ID: 24573719
[TBL] [Abstract][Full Text] [Related]
20. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats.
Duman DG; Kumral ZN; Ercan F; Deniz M; Can G; Cağlayan Yeğen B
Br J Nutr; 2013 Aug; 110(3):493-9. PubMed ID: 23279717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
